Patents by Inventor Marie-Claire Fichot
Marie-Claire Fichot has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).
-
Patent number: 9462821Abstract: A method of reducing the accumulation of fat mass in a neonatal human infant at risk thereof which method comprises administering to the infant during at least a part of the neonatal period a therapeutic amount of a nutritional composition comprising proteins in an amount such that the composition contains more than 2.4 g of protein per 100 kcal. As weight gain during the first week of life has been associated with overweight in adulthood, this may offer a method of reducing the risk of developing obesity in later life. Also claimed is the administration of DHA to the mother during gestation period.Type: GrantFiled: November 23, 2009Date of Patent: October 11, 2016Assignee: Nestec S.A.Inventors: Marie-Claire Fichot, Catherine Mace, Philippe Steenhout
-
Patent number: 9247764Abstract: A nutritional composition for administration to an infant which composition comprises, on a dry matter basis, from 2.5 to 15.0 wt % of an oligosaccharide mixture consisting of N-acetylated oligosaccharide(s), galacto-oligosaccharide(s) and sialylated oligosaccharide(s) with the proviso that the composition comprises at least 0.02 wt % of an N-acetylated oligosaccharide, at least 2.0 wt % of a galacto-oligosaccharide and at least 0.04 wt % of a sialylated oligosaccharide and that the N-acetylated oligosaccharide(s) comprise 0.5 to 4.0% of the oligosaccharide mixture, the galacto-oligosaccharide(s) comprise 92.0 to 98.5% of the oligosaccharide mixture and the sialylated oligosaccharide(s) comprise 1.0 to 4.0% of the oligosaccharide mixture. The composition is useful for administration to an infant in the first six months of life to reduce the risk of obesity later in life.Type: GrantFiled: September 29, 2014Date of Patent: February 2, 2016Assignee: Nestec S.A.Inventors: Marie-Claire Fichot, Norbert Sprenger, Francois-Pierre Martin, Sunil Kochhar, Serge Rezzi
-
Patent number: 9226945Abstract: A nutritional composition comprising a partially hydrolyzed milk protein having a degree of hydrolysis between 15 and 25% and 50 to 1000 nanograms of TGF-? per 100 ml of ready to consume composition and methods for the primary prevention of allergic reactions to newly introduced dietary protein at weaning and the prevention of development of atopic diseases in a young mammal at weaning comprising feeding to the young mammal a therapeutic amount of the composition are disclosed.Type: GrantFiled: February 22, 2013Date of Patent: January 5, 2016Assignee: Nestec S.A.Inventors: Annick Mercenier, Marie-Claire Fichot, Adrian Zuercher
-
Patent number: 9060540Abstract: Use of probiotic bacteria in the manufacture of a medicament or therapeutic nutritional composition for increasing IgA secretion in an infant delivered by cesarean section during the first four months of the life of the infant.Type: GrantFiled: July 15, 2009Date of Patent: June 23, 2015Assignee: Nestec S.A.Inventors: Florence Rochat, Marie-Claire Fichot
-
Publication number: 20150030720Abstract: A nutritional composition for administration to an infant which composition comprises, on a dry matter basis, from 2.5 to 15.0 wt % of an oligosaccharide mixture consisting of N-acetylated oligosaccharide(s), galacto-oligosaccharide(s) and sialylated oligosaccharide(s) with the proviso that the composition comprises at least 0.02 wt % of an N-acetylated oligosaccharide, at least 2.0 wt % of a galacto-oligosaccharide and at least 0.04 wt % of a sialylated oligosaccharide and that the N-acetylated oligosaccharide(s) comprise 0.5 to 4.0% of the oligosaccharide mixture, the galacto-oligosaccharide(s) comprise 92.0 to 98.5% of the oligosaccharide mixture and the sialylated oligosaccharide(s) comprise 1.0 to 4.0% of the oligosaccharide mixture. The composition is useful for administration to an infant in the first six months of life to reduce the risk of obesity later in life.Type: ApplicationFiled: September 29, 2014Publication date: January 29, 2015Inventors: Marie-Claire Fichot, Norbert Sprenger, Francois-Pierre Martin, Sunil Kochhar, Serge Rezzi
-
Patent number: 8846642Abstract: A nutritional composition for administration to an infant which composition comprises, on a dry matter basis, from 2.5 to 15.0 wt % of an oligosaccharide mixture consisting of N-acetylated oligosaccharide(s), galacto-oligasaccharide(s) and sialylated oligosaccharide(s) with the proviso that the composition comprises at least 0.02 wt % of an N-acetylated oligosaccharide, at least 2.0 wt % of a galacto-oligosaccharide and at least 0.04 wt % of a sialylated oligosaccharide and that the N-acetylated oligosaccharide(s) comprise 0.5 to 4.0% of the oligosaccharide mixture, the galacto-oligosaccharide(s) comprise 92.0 to 98.5% of the oligosaccharide mixture and the sialylated oligosacchardide(s) comprise 1.0 to 4.0% of the oligosaccharide mixture. The composition is useful for administration to an infant in the first six months of life to reduce the risk of obesity later in life.Type: GrantFiled: April 10, 2013Date of Patent: September 30, 2014Assignee: Nestec S.A.Inventors: Marie-Claire Fichot, Norbert Sprenger, Francois-Pierre Martin, Sunil Kochhar, Serge Rezzi
-
Patent number: 8771780Abstract: An oligosaccharide ingredient comprising glycosylated amino acids and peptides of the general formula RnSacm where R is an amino acid residue, Sac is a monosaccharide selected from the group comprising N-acetyl-neuraminic acid, N-acetyl galactosamine and galactose, n has a value between 1 and 10 with the proviso that if n has the value 1 R is a threonine residue or a serine residue and if n has a value between 2 and 10 the peptide contains at least one threonine or serine residue, m has a value between 2 and 4 and at least 20 mol % of the ingredient is N-acetyl-neuraminic acid.Type: GrantFiled: March 4, 2009Date of Patent: July 8, 2014Assignee: Nestec S.A.Inventors: Norbert Sprenger, Rafael Berrocal, Marie-Claire Fichot
-
Publication number: 20140079845Abstract: An oligosaccharide ingredient comprising glycosylated amino acids and peptides of the general formula RnSacm where R is an amino acid residue, Sac is a monosaccharide selected from the group comprising N-acetyl-neuraminic acid, N-acetyl galactosamine and galactose, n has a value between 1 and 10 with the proviso that if n has the value 1 R is a threonine residue or a serine residue and if n has a value between 2 and 10 the peptide contains at least one threonine or serine residue, m has a value between 2 and 4 and at least 20 mol % of the ingredient is N-acetyl-neuraminic acid.Type: ApplicationFiled: November 21, 2013Publication date: March 20, 2014Applicant: NESTEC S.A.Inventors: Rafael Berrocal, Marie-Claire Fichot, Norbert Sprenger
-
Patent number: 8617631Abstract: An oligosaccharide ingredient comprising glycosylated amino acids and peptides of the general formula RnSacm where R is an amino acid residue, Sac is a monosaccharide selected from the group comprising N-acetyl-neuraminic acid, N-acetyl galactosamine and galactose, n has a value between (1) and (10) with the proviso that if n has the value (1) R is a threonine residue or a serine residue and if n has a value between (2) and (10) the peptide contains at least one threonine or serine residue, m has a value between (2) and (4) and at least (20) mol % of the ingredient is N-acetyl-neuraminic acid.Type: GrantFiled: February 25, 2009Date of Patent: December 31, 2013Assignee: Nestec S.A.Inventors: Rafael Berrocal, Marie-Claire Fichot, Norbert Sprenger
-
Patent number: 8586563Abstract: A nutritional composition for administration to an infant which composition comprises, on a dry matter basis, from 2.5 to 15.0 wt % of an oligosaccharide mixture consisting of N-acetylated oligosaccharide(s), galacto-oligosaccharide(s) and sialylated oligosaccharide(s) with the proviso that the composition comprises at least 0.02 wt % of an N-acetylated oligosaccharide, at least 2.0 wt % of a galacto-oligosaccharide and at least 0.04 wt % of a sialylated oligosaccharide and that the N-acetylated oligosaccharide(s) comprise 0.5 to 4.0% of the oligosaccharide mixture, the galacto-oligosaccharide(s) comprise 92.0 to 98.5% of the oligosaccharide mixture and the sialylated oligosaccharide(s) comprise 1.0 to 4.0% of the oligosaccharide mixture. The composition is useful for administration to an infant in the first six months of life to reduce the risk of obesity later in life.Type: GrantFiled: June 19, 2009Date of Patent: November 19, 2013Assignee: Nestec S.A.Inventors: Marie-Claire Fichot, Norbert Sprenger, Francois-Pierre Martin, Sunil Kochhar, Serge Rezzi
-
Patent number: 8562971Abstract: The use of a probiotic Lactobacillus rhamnosus and a probiotic Bifidobacterium longumin the manufacture of a medicament or therapeutic nutritional composition for administration to an infant during at least the first three months of life for the long-term prophylaxis of diarrhea in infants and young children.Type: GrantFiled: February 20, 2008Date of Patent: October 22, 2013Assignee: Nestec S.A.Inventors: Florence Rochat, Karl-Josef Huber-Haag, Marie-Claire Fichot
-
Publication number: 20130131014Abstract: This invention relates to a synthetic nutritional composition suitable for use in the prevention of secondary infections following a viral infection characterised by neuraminidase activity comprising a sialylated oligosaccharide and N-acetyl-lactosamine and/or an oligosaccharide containing N-acetyl-lactosamine. The invention further extends to the use of such a composition in the prevention of secondary infections such as otitis media.Type: ApplicationFiled: January 15, 2013Publication date: May 23, 2013Applicant: Nestec S.A.Inventors: Marie-Claire Fichot, Norbert Sprenger
-
Patent number: 8383587Abstract: A nutritional composition comprising a partially hydrolysed milk protein having a degree of hydrolysis between 15 and 25% and 50 to 1000 nanograms of TGF-? per 100 ml of ready to consume composition and methods for the primary prevention of allergic reactions to newly introduced dietary protein at weaning and the prevention of development of atopic diseases in a young mammal at weaning comprising feeding to the young mammal a therapeutic amount of the composition are disclosed.Type: GrantFiled: September 19, 2008Date of Patent: February 26, 2013Assignee: Nectec S.A.Inventors: Annick Mercenier, Marie-Claire Fichot, Adrian Zuercher
-
Patent number: 8377430Abstract: The invention relates to an infant formula comprising a source of protein in an amount of not more than 2.0 g/100 kcal, a source of lipids, a source of carbohydrate and a probiotic wherein the probiotic is present in an amount equivalent to between 102 and 105 cfu/g of dry formula. The invention further extends to the use of such an infant formula to modulate the immune system of a neonatal infant to promote the development in the first few weeks of the life of the infant of a beneficial intestinal microbiota comparable with that found in breast fed babies as well as to promote the maturation of the immune system of a neonatal infant in the first few weeks of life.Type: GrantFiled: April 10, 2006Date of Patent: February 19, 2013Assignee: Nestec S.A.Inventors: Anne Donnet-Hughes, Eduardo Schiffrin, Ferdinand Haschke, Marie-Claire Fichot, Karl-Josef Huber-Haag
-
Publication number: 20120045566Abstract: An oligosaccharide ingredient comprising glycosylated amino acids and peptides of the general formula RnSacm where R is an amino acid residue, Sac is a monosaccharide selected from the group comprising N-acetyl-neuraminic acid, N-acetyl galactosamine and galactose, n has a value between 1 and 10 with the proviso that if n has the value 1 R is a threonine residue or a serine residue and if n has a value between 2 and 10 the peptide contains at least one threonine or serine residue, m has a value between 2 and 4 and at least 20 mol % of the ingredient is N-acetyl-neuraminic acid.Type: ApplicationFiled: March 4, 2009Publication date: February 23, 2012Applicant: NESTEC S.A.Inventors: Norbert Sprenger, Rafael Berrocal, Marie-Claire Fichot
-
Publication number: 20110244072Abstract: A method of reducing the accumulation of fat mass in a neonatal human infant at risk thereof which method comprises administering to the infant during at least a part of the neonatal period a therapeutic amount of a nutritional composition comprising proteins in an amount such that the composition contains more than 2.4 g of protein per 100 kcal. As weight gain during the first week of life has been associated with overweight in adulthood, this may offer a method of reducing the risk of developing obesity in later life. Also claimed is the administration of DHA to the mother during gestation period.Type: ApplicationFiled: November 23, 2009Publication date: October 6, 2011Applicant: NESTEC S.A.Inventors: Marie-Claire Fichot, Catherine Mace, Philippe Steenhout
-
Publication number: 20110223137Abstract: The present invention relates to compositions for use in low-birth weight infants. In particular, the compositions are probiotic compositions which are used for achieving full enteral feeding in low birth weight infants. The invention is also concerned with the use of specific probiotics in the manufacture of low-birth weight infant formulations.Type: ApplicationFiled: November 23, 2009Publication date: September 15, 2011Applicant: NESTEC S.A.Inventors: Dominique Darmaun, Marie-Claire Fichot, Hugues Piloquet, Florence Rochat, Carole Rouge, Jean-Christophe Roze
-
Publication number: 20110129452Abstract: Use of probiotic bacteria in the manufacture of a medicament or therapeutic nutritional composition for increasing IgA secretion in an infant delivered by cesarean section during the first four months of the life of the infant.Type: ApplicationFiled: July 15, 2009Publication date: June 2, 2011Applicant: NESTEC S.A.Inventors: Florence Rochat, Marie-Claire Fichot
-
Publication number: 20110110904Abstract: A nutritional composition for administration to an infant which composition comprises, on a dry matter basis, from 2.5 to 15.0 wt % of an oligosaccharide mixture consisting of N-acetylated oligosaccharide(s), galacto-oligosaccharide(s) and sialylated oligosaccharide(s) with the proviso that the composition comprises at least 0.02 wt % of an N-acetylated oligosaccharide, at least 2.0 wt % of a galacto-oligosaccharide and at least 0.04 wt % of a sialylated oligosaccharide and that the N-acetylated oligosaccharide(s) comprise 0.5 to 4.0% of the oligosaccharide mixture, the galacto-oligosaccharide(s) comprise 92.0 to 98.5% of the oligosaccharide mixture and the sialylated oligosaccharide(s) comprise 1.0 to 4.0% of the oligosaccharide mixture. The composition is useful for administration to an infant in the first six months of life to reduce the risk of obesity later in life.Type: ApplicationFiled: June 19, 2009Publication date: May 12, 2011Applicant: NESTEC S.A.Inventors: Marie-Claire Fichot, Norbert Sprenger, Francois-Pierre Martin, Sunil Kochhar, Serge Rezzi
-
Publication number: 20110064707Abstract: The use of probiotic bacteria in the manufacture of a medicament or therapeutic nutritional composition for promoting the development of an early bifidogenic intestinal microbiota in infants without siblings.Type: ApplicationFiled: May 12, 2009Publication date: March 17, 2011Applicant: NESTEC S.A.Inventors: Florence Rochat, Marie-Claire Fichot